Actively Recruiting
Evaluating Low-Level Laser Therapy for Adults with Chronic Fatigue Syndrome to Reduce Fatigue and Improve Quality of Life
Led by University of Lahore · Updated on 2026-10-08
40
Participants Needed
1
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether photobiomodulation therapy, also known as low-level laser therapy, can reduce fatigue and improve quality of life in adults aged 18 to 60 years diagnosed with chronic fatigue syndrome CFS. This study compares the effects of active low-level laser therapy with a placebo treatment to determine if it helps lessen fatigue and improve pain, functional capacity, sleep quality, and psychological well-being. Participants will be randomly assigned to receive either active low-level laser therapy or a sham laser treatment that looks the same but does not emit therapeutic energy. The therapy targets multiple muscle groups on both sides of the body, with sessions conducted three times per week over an eight-week period, totaling 24 sessions. Each muscle receives treatment at multiple points with a set energy dose. During the study, participants will undergo assessments at the start and at 3, 6, and 12 months after treatment to measure fatigue levels, pain, functional abilities, sleep quality, psychological health, and overall quality of life. Researchers will monitor safety, tolerability, and any adverse effects throughout the treatment and follow-up periods to understand the therapys lasting impact.
CONDITIONS
Brief Title
Photobiomodulation in Chronic Fatigue Syndrome
Research Team
D
Dr Adil Amir Ali Dr Aadil Amir Ali, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here